Ascentis Independent Advisors

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1845003 DALLAS, TX

Position in TMO

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$2,614,443

+$1,088,172 QoQ

Shares Held

5,319

+101.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Ascentis Independent Advisors holds $4,343,093 across 21 Diagnostics & Research names. TMO ranks #1 (60.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc. This page	5,319	$2,614,443
2	DHR	Danaher Corp /De/	5,432	$1,029,905
3	DGX	Quest Diagnostics Inc	1,428	$279,857
4	NTRA	Natera, Inc.	556	$111,193
5	VCYT	Veracyte, Inc.	3,300	$106,293
6	GH	Guardant Health, Inc.	408	$37,685
7	RVTY	Revvity, Inc.	327	$28,647
8	IQV	Iqvia Holdings Inc.	148	$25,239

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,614,443	5,319	+101.9%	Shares	Sole	2026-04-28
2025-12-31	$1,526,271	2,634	+1.4%	Shares	Sole	2026-01-29
2025-09-30	$1,259,596	2,597	-13.9%	Shares	Sole	2025-10-21
2025-06-30	$1,223,678	3,018	+210.8%	Shares	Sole	2025-07-14
2025-03-31	$483,169	971	+2.3%	Shares	Sole	2025-04-23
2024-12-31	$493,698	949	+63.1%	Shares	Sole	2025-01-24
2024-09-30	$359,951	582	-6.0%	Shares	Sole	2024-10-29
2024-06-30	$342,307	619	-4.9%	Shares	Sole	2024-07-29
2023-12-31	$345,544	651	+68.7%	Shares	Sole	2024-02-02
2023-06-30	$201,395	386	-59.5%	Shares	Sole	2023-07-19
2021-12-31	$635,212	952	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.